Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2012-08-23 Regulatory Filings
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2012
Regulatory Filings
2012-08-23 English
BOVIE 13G/A
Major Shareholding Notification
2012-08-16 English
Regulatory Filings 2012
Regulatory Filings Classification · 95% confidence The document is a letter from the company's legal counsel responding to comments from the SEC staff regarding the company's previously filed Form 10-K for the fiscal year ended December 31, 2011. It references amendments to the Form 10-K and Form 8-K/A that will be filed in response to the SEC's comments. The letter discusses specific disclosure issues and planned amendments but does not itself contain the full annual report or financial statements. It is a regulatory correspondence related to the filing process rather than the report itself. Therefore, this document is best classified as a Regulatory Filing (RNS), which is the fallback category for such correspondence and comment responses to regulatory bodies.
2012-08-16 English
BOVIE MEDICAL CORP 10-K A 12-31-2011
Annual Report FY 2011
2012-08-16 English
BOVIE MEDICAL CORPORATION 8-K A 2-22-2012
Regulatory Filings Classification · 95% confidence The document is a Form 8-K/A, which is an amendment to a previously filed Form 8-K. It references a Confidential Settlement Agreement and Mutual General Release and is filed pursuant to the Securities Exchange Act of 1934. The document is an SEC current report amendment, not a full financial report or earnings release. It primarily serves to update or amend a prior filing and includes exhibits related to a settlement agreement. The document length is 3153 characters, which is relatively short and consistent with an amendment or regulatory filing rather than a full report. Therefore, this document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2012-08-16 English
BOVIE MEDICAL CORPORATION 10-Q 6-30-2012
Interim / Quarterly Report H1 2012
2012-08-14 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.